Generating tissue-engineered intestinal epithelium from cultured Lgr5 stem cells in vivo  by Baimakhanov, Zhassulan et al.
lable at ScienceDirect
Regenerative Therapy 5 (2016) 46e48Contents lists avaiRegenerative Therapy
journal homepage: http: / /www.elsevier .com/locate/rethOriginal ArticleGenerating tissue-engineered intestinal epithelium from cultured
Lgr5 stem cells in vivo
Zhassulan Baimakhanov, Yasuhiro Torashima, Akihiko Soyama, Yusuke Inoue,
Yusuke Sakai, Mitsuhisa Takatsuki, Fumihiko Fujita, Kengo Kanetaka, Tamotsu Kuroki,
Susumu Eguchi*
Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Japana r t i c l e i n f o
Article history:
Received 29 March 2016
Received in revised form
17 June 2016





CryptAbbreviations: PAS, periodic acid-Schiff staining;
intestine.
* Corresponding author. Department of Surgery, N
School of Biomedical Sciences, 1-7-1 Sakamoto, Nagas
95 819 7319.
E-mail address: sueguchi@nagasaki-u.ac.jp (S. Egu
Peer review under responsibility of the Japane
Medicine.
http://dx.doi.org/10.1016/j.reth.2016.08.002
2352-3204/© 2016, The Japanese Society for Regener
(http://creativecommons.org/licenses/by-nc-nd/4.0/).a b s t r a c t
Introduction: Generating tissue-engineered small intestine (TESI) from mature intestinal cells has been
established in a mouse model. The purpose of this study was to generate TESI from Lgr5 stem cells
in vivo.
Methods: We used Lgr5-EGFP mice for intestinal crypt isolation. After seven days, cultured crypts with
Lgr5 stem cells were seeded onto a biodegradable polymer and implanted into omentum of NOD/SCID
mice.
Results: Engineered intestinal epithelium was generated from Lgr5 stem cells after four weeks of in vivo
implantation. Intestinal epithelium was immunohistochemically positive for Paneth cells, enter-
oendocrine cells, goblet cells, microvilli of the absorptive enterocytes and Ki67.
Conclusion: Our observations suggest that transplanted Lgr5 stem cells can differentiate into the intes-
tinal epithelium in vivo with further proliferative activity.
© 2016, The Japanese Society for Regenerative Medicine. Production and hosting by Elsevier B.V. This is
an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).The procedure for generating tissue-engineered small intestine
(TESI) from donor mature intestinal cells has been established in an
animal model [1,2]. Histologically, the engineered small intestine
was similar to the native intestine and containedwell differentiated
epithelium, muscularis, nerves and blood vessels [2]. Previous ex-
periments showed that the TESI could be used as part of an effective
treatment strategy in the rat short bowel syndrome model, and
could increase the postoperative weight [1]. Additionally, TESI
generated from human and mouse small intestines were trans-
planted into immunodeﬁcient host mouse omentum, and the
resulting intestines demonstrated digestive and absorptive func-
tionality, including the ability to absorb sugars [3]. However,
despite the progress in research related to the method to generateTESI, tissue-engineered small
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treatment in clinical practice. One of the main unresolved issues is
that current protocols for making TESI require a large number of
mature donor intestinal cells, which can cause considerable difﬁ-
culties due to the critical shortage of donor organs. Therefore,
alternative sources of the cells are required. Previously, it has been
shown that Lgr5 stem cells constitute multipotent stem cells and
generate all cell types of the intestinal epithelium [4]. Furthermore,
long term in vitro culture conditions have been established, under
which organoids were cultured for more than 8 months with
continuously expanding, self-organizing crypt-villus like epithelial
structures [5].
Considering the previously reported results, in the current
study, we aimed to generate the TESI from cultured Lgr5 stem cells
in vivo. To investigate this possibility, we isolated and cultured
small intestinal crypts from heterozygous Lgr5-EGFP-cre/ERT2
mice (both sexes after genotyping, 6e10 weeks; The Jackson Lab-
oratory, Maine, USA) according to the previous reports [4,5]. NOD/
SCID mice (female, 7e8 weeks; Charles River Laboratories Japan,
Inc., Yokohama) were used as the recipients. Our experiments
consisted of at least six different time points, with independent
cell preparations every time. All experiments were performedsting by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
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saki University. Single isolated crypts cells were cultured in
Matrigel (200 crypts per well on 24-well plates). The culture me-
dium containing growth factors (10e50 ng ml1 EGF (Peprotech),
500 ng ml1 R-spondin 1 and 100 ng ml1 Noggin (Peprotech)) was
changed every two or three days as previously described [5]. After
seven or eight days in a culture without subculturing, the super-
natant medium was removed and cultured organoids were me-
chanically collected with Matrigel by adding the cold culture
medium. The supernatant was removed after centrifugation at
70  g for 5 min and the pellet containing the crypt organoids was
resuspended with Matrigel. For the in vivo implantation, nonwoven
polyglycolic acid (2 mm thickness, 55 mg/cm3 bulk density; Biofelt,
Luxembourg) was used for the scaffold preparation as previously
described [2]. The crypt organoids (2000 crypts per scaffold) were
loaded on the biodegradable scaffold and directly implanted into
the omentum of the NOD/SCID mice and ﬁxed by 6-0 Prolene su-
ture. The recipient mice were sacriﬁced at four weeks after im-
plantation for an immunohistological analysis. All tissue samples
were ﬁxed with 4% paraformaldehyde in phosphate buffered so-
lution and embedded in parafﬁn with subsequent slicing into 5 mm
sections. Hematoxylin and eosin staining was performed according
to the standard staining protocol and periodic acid-Schiff staining
was according to the manufacturer's protocol (PAS staining kit,
Merck KGaa, Darmstadt, Germany). For the immunological staining,
deparafﬁnized tissue sections were treated with heat-induced an-
tigen retrieval (using an autoclave) in a 1 mM EDTA buffer solution
containing 10 mM TriseHCl (pH 9.0). The samples were incubated
with the following primary antibodies at 4 C overnight: anti-
mouse lysozyme, Chromogranin A, E-cadherin, villin (all from
Santa Cruz Biotechnology Inc., Dallas, USA), a rabbit polyclonal anti-
SCG l0 antibody [6], anti-mouse GFP and Ki67 (both from Abcam,
MA, USA). The samples were then incubated with secondary anti-
bodies (all from Sigma Aldrich, Missouri, USA) for 1 h at roomFig. 1. Generated small intestinal epithelium from cultured Lgr5 stem cells four weeks after
and into a spherical form relative to the initial scaffold size. (B, C) Hematoxylin and eosin s
multiple blood vessels (C; arrowheads), which formed cyst-like structures with the cavity. I
epithelium (D), the Lgr5-GFPþ labeled cell marker at the bottom of the engineered intestin
used as the positive. Scale bars: 100 mm.temperature. The slides were then treated with the DAB substrate-
chromogen system (DAKO, CA, USA).
At four weeks after transplantation, implanted Lgr5 stem cells in
the biodegradable scaffold had grown larger and into a spherical
form (Fig. 1A). The histological analysis revealed that the generated
TESI from Lgr5 stem cells had proliferated. Additionally, a large
quantity of differentiated mucosal epithelium was observed
(Fig. 1B) with surrounding multiple blood vessels (Fig. 1C) and
formed cyst-like structures with the cavity. Furthermore, neuronal
cells around the generated intestinal epithelium (Fig. 1D) were
observed using SCG 10 antibody, which has been shown to be a
strong neuronal growth-associated protein marker [6]. The cell
origin of the generated TESI was immunohistologically conﬁrmed
by detection of the speciﬁc Lgr5-GFPþ labeled cell marker at the
bottom of the engineered intestinal crypt (Fig. 1E). The small in-
testine of a Lgr5-EGFP-cre/ERT2 donormouse (Fig.1F) was used as a
positive control. Further, we conﬁrmed that the epithelial differ-
entiation was comparable to that of the native small intestine. The
intestinal epithelium in generated TESI was immunohistochemi-
cally positive for goblet cells (Fig. 2A; PAS staining), Paneth cells
(Fig. 2B; lysozyme), microvilli of the absorptive enterocytes (Fig. 2C;
villin), enteroendocrine cells (Fig. 2D; Chromogranin A), epithelial
adherens junction protein e E-cadherin (Fig. 2E) and were still
strongly positive for the proliferation marker Ki67 (Fig. 2F).
The herein described technique was successful in transplanting
Lgr5 stem cell that differentiated into the intestinal epithelium
in vivo. Furthermore, at four weeks after implantation, there
remained a large number of Ki67-positive epithelial cells. There-
fore, the proliferative activity of the intestinal epithelium and the
maintenance of the intestinal morphology containing all four
differentiated epithelial cells were conﬁrmed. There are limitations
to this protocol because of a lack of muscularis in the generated
TESI. Future research into co-culture methods with mesenchymal
stromal cells to generate the muscular layer in the TESI is beingtransplantation. (A) A macroscopic observation showed that the TESI had grown larger
taining showed a large quantity of differentiated mucosal epithelium surrounded with
mmunohistochemistry conﬁrmed the existence of neuronal cells around the intestinal
al crypt (E; arrows). The small intestine of a Lgr5-EGFP-cre/ERT2 donor mouse (F) was
Fig. 2. Morphology of the differentiated intestinal epithelium in generated TESI from cultured Lgr5 stem cells four weeks after transplantation. The PAS staining showed goblet cells
(A). Immunohistochemical staining showed the existence of Paneth cells (B), microvilli of the absorptive enterocytes (C), enteroendocrine cells (D), epithelial adherens junction
protein e E-cadherin (E) and the expression of the proliferation marker Ki67 (F). Scale bars: 100 mm.
Z. Baimakhanov et al. / Regenerative Therapy 5 (2016) 46e4848considered. Nevertheless, under pathological conditions like in-
ﬂammatory bowel disease, rapid regenerative response is probably
complicated from the endogenous cell source alone. Therefore, we
believe that the current technique of generating small intestinal
epithelium from Lgr5 stem cells offers a viable therapeutic oppor-
tunity for the treatment of inﬂammatory bowel disease by
encouraging regeneration to damaged epithelia. Further in-
vestigations of this protocol should be conducted to determine the
effectiveness of ex-vivo expanded epithelial stem cells trans-
plantation technology, which may generate novel clinical applica-
tions for improving the intestinal function and have implications
for tissue replacement.
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